Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Anticancer Research|June 30, 2016
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial ChemoembolizationMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Journal of Gastroenterology and Hepatology|August 12, 2016
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patientsKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2017
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinomaYuji Teraoka, Tomoki Kimura, Hiroshi Aikata, et al.The Journal of Infection|December 26, 2021
Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibodyHaruna Hatooka, Yumi Shimomura, Michio Imamura, et al.Molecular Medicine Reports|November 12, 2020
<i>In vitro</i> analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphismSongyao Liu, Eisuke Murakami, Takashi Nakahara, et al.Journal of Gastroenterology and Hepatology|January 3, 2020
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy casesKana Daijo, Takashi Nakahara, Yuki Inagaki, et al.BMC Cancer|June 6, 2018
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trialMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Journal of Medical Virology|June 29, 2017
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patientsHiromi Kan, Michio Imamura, Yoshiiku Kawakami, et al.European Radiology|June 4, 2015
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinomaTomoki Kobayashi, Hiroshi Aikata, Masahiro Hatooka, et al.Journal of Viral Hepatitis|June 9, 2021
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patientsYuno Nishida, Michio Imamura, Yuji Teraoka, et al.Pageof 8